Cargando…

Feasibility of gadoxetate disodium enhanced 3D T1 MR cholangiography (MRC) with a specific inversion recovery prepulse for the assessment of the hepatobiliary system

AIM: To compare the potential of a gadoxetate disodium enhanced navigator-triggered 3D T1 magnetic-resonance cholangiography (MRC) sequence with a specific inversion recovery prepulse to T2-weighted MRCP for assessment of the hepatobiliary system. MATERIALS AND METHODS: 30 patients (12 male, 18 fema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fahlenkamp, Ute Lina, Adams, Lisa Christine, Böker, Sarah Maria, Engel, Günther, Huynh Anh, Minh, Wagner, Moritz, Hamm, Bernd, Makowski, Marcus Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124795/ https://www.ncbi.nlm.nih.gov/pubmed/30183778 http://dx.doi.org/10.1371/journal.pone.0203476

Ejemplares similares

Improved visualisation of hepatic metastases in gadoxetate disodium-enhanced MRI: Potential of contrast-optimised (phase-sensitive) inversion recovery imaging
por: Fahlenkamp, Ute Lina, et al.
Publicado: (2019)

Does gadoxetate disodium affect MRE measurements in the delayed hepatobiliary phase?
por: Plaikner, M., et al.
Publicado: (2018)

Intracellular accumulation capacity of gadoxetate: initial results for a novel biomarker of liver function
por: Fahlenkamp, Ute Lina, et al.
Publicado: (2020)

Biliary Anastomotic Leakage following Orthotopic Liver Transplant: The Use of Primovist (Gadoxetate Disodium) as an Intravenous MR Cholangiography Contrast Agent for Biliary Leakage
por: Blair, Peter S, et al.
Publicado: (2014)

Troubleshooting Arterial-Phase MR Images of Gadoxetate Disodium-Enhanced Liver
por: Huh, Jimi, et al.
Publicado: (2015)

Intrahepatic diffuse periportal enhancement patterns on hepatobiliary phase gadoxetate disodium-enhanced liver MR images: Do they correspond to periportal hyperintense patterns on T2-weighted images?
por: Onishi, Hiromitsu, et al.
Publicado: (2019)

Prediction of Sufficient Liver Enhancement on the Gadoxetate Disodium-enhanced Hepatobiliary Phase Imaging Using Transitional Phase Images and Albumin–bilirubin Grade
por: Takatsu, Yasuo, et al.
Publicado: (2020)

Shrunken Hepatic Hemangioma Following Delineated Peritumoral Hyperintensity on Gadoxetic Acid Disodium-enhanced MR Imaging
por: Haradome, Hiroki, et al.
Publicado: (2017)

Safety profile of gadoxetate disodium in elderly patients (≥65 years)
por: Endrikat, Jan, et al.
Publicado: (2017)

The MR imaging diagnosis of liver diseases using gadoxetic acid: Emphasis on hepatobiliary phase
por: Jeong, Woo Kyoung, et al.
Publicado: (2013)

Characteristics of Hepatic Schwannoma Presenting as an Unusual Multi-cystic Mass on Gadoxetic Acid Disodium-enhanced MR Imaging
por: Haradome, Hiroki, et al.
Publicado: (2017)

Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma
por: Ricke, Jens, et al.
Publicado: (2020)

Utility of Wavelet Denoising with Geometry Factor Weighting for Gadoxetic Acid-enhanced Hepatobiliary-phase MR Imaging
por: Kondo, Shota, et al.
Publicado: (2022)

Diagnosis of Cholecysto-Colonic Fistula Using Gadoxetic Acid – Magnetic Resonance Cholangiography
por: Mourri, A. B., et al.
Publicado: (2015)

Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers
por: Lochrin, Sarah E., et al.
Publicado: (2021)

Radiomics Model Based on Gadoxetic Acid Disodium-Enhanced MR Imaging to Predict Hepatocellular Carcinoma Recurrence After Curative Ablation
por: Zhang, Ling, et al.
Publicado: (2021)

Portal Hypertension may Influence the Registration of Hypointensity of Small Hepatocellular Carcinoma in the Hepatobiliary Phase in Gadoxetic Acid MR
por: Caparroz, Carla, et al.
Publicado: (2022)

Optimal Combination of Features on Gadoxetate Disodium-enhanced MR Imaging for Non-invasive Differential Diagnosis of Hepatocellular Carcinoma: The JAMP-HCC Study
por: Ichikawa, Shintaro, et al.
Publicado: (2020)

Gadoxetate Disodium enhanced spectral dual-energy CT for evaluation of cholangiocarcinoma: Preliminary data
por: Thomas, John V., et al.
Publicado: (2016)

Analysis of the Performance of Gadoxetic Acid Disodium MRI in Predicting Microvascular Invasion of Hepatocellular Carcinoma
por: Chen, Jiao, et al.
Publicado: (2022)

Does Hepatic Steatosis Influence the Detection Rate of Metastases in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI?
por: Steffen, Ingo G., et al.
Publicado: (2020)

Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition
por: Ulloa, Jose L, et al.
Publicado: (2013)

Safety of gadoxetate disodium: results from six clinical phase IV studies in 8194 patients
por: Endrikat, Jan, et al.
Publicado: (2015)

Radiomics Analysis on Gadoxetate Disodium-Enhanced MRI Predicts Response to Transarterial Embolization in Patients with HCC
por: Cannella, Roberto, et al.
Publicado: (2022)

Value of susceptibility-weighted imaging for the assessment of angle measurements reflecting hip morphology
por: Böker, Sarah M., et al.
Publicado: (2020)

Author Correction: Value of susceptibility‑weighted imaging for the assessment of angle measurements reflecting hip morphology
por: Böker, Sarah M., et al.
Publicado: (2021)

Non-hypervascular Hypointense Nodules on Hepatocyte Phase Gadoxetic Acid-Enhanced MR Images: Transformation of MR Hepatobiliary Hypointense Nodules into Hypervascular Hepatocellular Carcinomas
por: Cho, Yun Ku, et al.
Publicado: (2018)

Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging for the Detection of Hepatocellular Carcinoma: A Meta-Analysis
por: Liu, Xijiao, et al.
Publicado: (2013)

Influence of age on gadoxetic acid disodium-induced transient respiratory motion artifacts in pediatric liver MRI
por: Hojreh, Azadeh, et al.
Publicado: (2022)

Predicting microvascular invasion in hepatocellular carcinoma: A dual‐institution study on gadoxetate disodium‐enhanced MRI
por: Jiang, Hanyu, et al.
Publicado: (2022)

Predicting histologic differentiation of solitary hepatocellular carcinoma up to 5 cm on gadoxetate disodium-enhanced MRI
por: Yang, Ting, et al.
Publicado: (2023)

Native T1 mapping for assessment of the perilesional zone in metastases and benign lesions of the liver
por: Fahlenkamp, Ute Lina, et al.
Publicado: (2020)

The role of gadoxetic acid-enhanced magnetic resonance cholangiography in the evaluation of postoperative bile duct injury: pictorial essay
por: Ribeiro, Bruno Jucá, et al.
Publicado: (2019)

Disodium gadoxetate uptake in progressive familial intrahepatic cholestasis type I: Enhancing our understanding of the cholestatic disease
por: Patel, Mikin V., et al.
Publicado: (2015)

Evaluation of late arterial acquisition and image quality after gadoxetate disodium injection using the CDT-VIBE sequence
por: Liu, Fen, et al.
Publicado: (2022)

Focal nodular hyperplasia: hepatobiliary enhancement patterns on gadoxetic-acid contrast-enhanced MRI
por: van Kessel, C. S., et al.
Publicado: (2012)

Transient Respiratory-motion Artifact and Scan Timing during the Arterial Phase of Gadoxetate Disodium-enhanced MR Imaging: The Benefit of Shortened Acquisition and Multiple Arterial Phase Acquisition
por: Ichikawa, Shintaro, et al.
Publicado: (2020)

Non-invasive detection of biliary leaks using Gd-EOB-DTPA-enhanced MR cholangiography: comparison with T2-weighted MR cholangiography
por: Kantarcı, Mecit, et al.
Publicado: (2013)

Meta-Analysis of Gadoxetic Acid Disodium (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging for the Detection of Liver Metastases
por: Chen, Lihua, et al.
Publicado: (2012)

Evaluation of transient respiratory motion artifact at gadoxetate disodium-enhanced MRI—Influence of different contrast agent application protocols
por: Ringe, Kristina I., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1hhv58mp9ofeirq78u339il20q